Neuland Laboratories Limited (BOM:524558)

Neuland Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1,319	875.75	454.16	50.91	24.36
Short-Term Investments	1,077	-	-	33.77	64.56
Cash & Short-Term Investments	2,396	875.75	454.16	84.68	88.91
Cash Growth	173.61%	92.83%	436.31%	-4.76%	-52.46%
Accounts Receivable	3,162	3,760	3,687	2,380	2,207
Other Receivables	79.78	70.45	31.6	35.16	16.66
Receivables	3,242	3,830	3,719	2,415	2,223
Inventory	3,858	3,504	2,792	2,652	2,476
Prepaid Expenses	117.18	111.41	105.38	74.16	71.75
Other Current Assets	1,782	889.07	538.4	582.18	635.87
Total Current Assets	11,395	9,211	7,609	5,808	5,496
Property, Plant & Equipment	7,183	5,686	4,980	4,866	4,312
Long-Term Investments	15.29	12.79	5.25	4.97	4.4
Goodwill	2,795	2,795	2,795	2,795	2,795
Other Intangible Assets	48.54	24.58	13.01	21.2	34.98
Other Long-Term Assets	362.74	596.7	395.86	340.41	605.74
Total Assets	21,799	18,326	15,798	13,835	13,248
Accounts Payable	2,522	1,920	1,710	1,174	1,521
Accrued Expenses	841.95	1,060	626.39	451.21	480.95
Short-Term Debt	-	-	111.58	922.15	569.84
Current Portion of Long-Term Debt	452.83	375.86	361.07	344.84	250.58
Current Portion of Leases	25.1	36.79	30.92	26.46	25.32
Current Income Taxes Payable	0.89	0.81	104.02	-	-
Other Current Liabilities	814.07	883.53	1,446	713.08	837.07
Total Current Liabilities	4,657	4,277	4,390	3,632	3,685
Long-Term Debt	907.27	449.21	742.46	1,042	881.33
Long-Term Leases	186.18	92.03	38.48	69.4	95.86
Long-Term Unearned Revenue	-	-	-	-	0.3
Long-Term Deferred Tax Liabilities	728.22	604.39	582.99	566.99	597.57
Other Long-Term Liabilities	48.5	39.56	33.11	32.52	54.53
Total Liabilities	6,551	5,499	5,857	5,430	5,383
Common Stock	128.3	128.3	128.3	128.3	128.3
Additional Paid-In Capital	4,978	4,978	4,978	4,978	4,978
Retained Earnings	10,225	7,804	4,931	3,360	2,761
Comprehensive Income & Other	-83.24	-82.79	-96.38	-61.31	-2.01
Total Common Equity	15,248	12,827	9,941	8,405	7,865
Shareholders' Equity	15,248	12,827	9,941	8,405	7,865
Total Liabilities & Equity	21,799	18,326	15,798	13,835	13,248
Total Debt	1,571	953.9	1,284	2,405	1,823
Net Cash (Debt)	824.76	-78.14	-830.34	-2,321	-1,734
Net Cash Per Share	64.28	-6.09	-64.72	-180.88	-135.15
Filing Date Shares Outstanding	12.83	12.83	12.83	12.83	12.83
Total Common Shares Outstanding	12.83	12.83	12.83	12.83	12.83
Working Capital	6,738	4,934	3,219	2,176	1,811
Book Value Per Share	1188.48	999.78	774.83	655.11	612.99
Tangible Book Value	12,405	10,008	7,133	5,589	5,035
Tangible Book Value Per Share	966.88	780.04	555.99	435.64	392.44
Land	330.91	287.48	107.43	107.43	107.43
Buildings	2,342	2,049	1,820	1,722	1,375
Machinery	6,554	5,336	4,635	4,337	3,754
Construction In Progress	445.53	458.91	405.66	204.57	172.5

Source: S&P Global Market Intelligence. Standard template. Financial Sources.